Skip to content
GLP-1-Based Therapeutics Summit

Returning in May 2025

Get Updates for the 2025 Meeting

Next Event in the Series: 2nd Obesity & Weight Loss Drug Development Summit

  • Home
  • About
    • About 2024 Event
    • Snapshot of 2024 Attendees
    • 2024 Exclusive Speaker Interview
    • Hanson Wade
  • 2024 Program
    • 2024 Event Program
    • 2024 Expert Speaker Faculty
  • Partner
    • Why Partner in 2025?
    • Partnership Prospectus
    • 2024 Partners
  • Register Interest for 2025
    • Register Interest
    • Get in Touch

Exclusive Speaker Interview

Scott Harris - Expert Speaker at the GLP-1-Based Therapeutics Summit

Scott Harris
Chief Medical Officer
Altimmune

Read Now
Speaker Interview - GLP-1-Based Therapeutics Summit
Register
See Full Agenda
Partner

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Searchlight Intelligence

SEARCH

ORGANIZED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

HWG

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok